ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
38 hedge funds and large institutions have $35.3M invested in Anthera Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
5% more capital invested
Capital invested by funds: $33.5M → $35.3M (+$1.78M)
Holders
38
Holding in Top 10
–
Calls
$147K
Puts
$115K
Top Buyers
| 1 | +$617K | |
| 2 | +$519K | |
| 3 | +$443K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$195K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$145K |
Top Sellers
| 1 | -$814K | |
| 2 | -$29.8K | |
| 3 | -$15.3K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$14.8K |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$6.29K |